Development of human papillomavirus plasmids capable of episomal replication in human cell lines

Gene Therapy

Volumn 6, Issue 7, 1999, Pages 1317-1321

  Sverdrup, F M ^a,b   Sheahan, L C ^a   Khan, S A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Sequitur Inc   (United States)

Author keywords

Autonomous replication; Cystic fibrosis; Human papillomavirus vectors

Indexed keywords

VIRUS VECTOR;

ARTICLE; CARCINOMA CELL; CELL LINE; DNA REPLICATION; DNA REPLICATION ORIGIN; EPISOME; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL; VIRUS GENE; WART VIRUS;

CYSTIC FIBROSIS; DNA-BINDING PROTEINS; GENE THERAPY; GENETIC VECTORS; HUMANS; ONCOGENE PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PLASMIDS; TUMOR CELLS, CULTURED; VIRAL PROTEINS; VIRUS REPLICATION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0032784629     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300957     Document Type: Article

References (35)

1. Robbins PD, Tahara H, Ghivizzani SC. Viral vectors for gene therapy. Trends Biotech 1998; 16: 35-40.
2. Sanalon Z et al. In vitro assembly of SV40 virions and pseudovirions. Vector development for gene therapy. Hum Gene Ther 1997; 8: 843-849.
3. Mulligan RC. The basic science of gene therapy. Science 1993; 260: 926-932.
4. Sugden B, Marsh K, Yates J. A vector that replicates as a plasmid and can be efficiently selected in B lymphocytes transformed by Epstein-Barr virus. Mol Cell Biol 1985; 5: 410-413.
5. Jolly D. Viral vector systems for gene therapy. Cancer Gene Ther 1994; 1: 51-64.
6. zur Hausen H, de Villiers EM. Heterogeneity of the human papillomavirus group. J Virol 1994; 63: 4898-4903.
7. Howley PM. Papillomavirinae: the viruses and their replication. In: Fields, BN, Knipe DM, Howley P (eds). Fields Virology, third edition. Lippincott-Raven: Philadelphia, 1996, pp 2045-2076.
8. McCance DJ. Human papillomaviruses and cancer. Biochim Biophys Acta 1986; 823: 195-205.
9. Lambert PF. Papillomavirus DNA replication. J Virol 1991; 65: 3417-3420.
10. Chow LT, Broker TR. Papillomavirus DNA replication. Intervirology 1994; 37: 150-158.
11. Ustav M, Stenlund A. Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J 1991; 10: 449-457.
12. Chiang C-M et al. Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins. Proc Natl Acad Sci USA 1992; 89: 5799-5803.
13. Del Vecchio AM, Romanczuk H, Howley PM, Baker CC. Transient replication of human papillomavirus DNAs. J Virol 1992; 66: 5949-5958.
14. Sverdrup F, Khan SA. Replication of human papillomavirus DNAs supported by the HPV-18 E1 and E2 proteins. J Virol 1994; 68: 505-509.
15. Gopalakrishnan V, Khan SA. The E1 protein of human papillomavirus type la is sufficient for the initiation of viral DNA replication. Proc Natl Acad Sci USA 1994; 91: 9597-9601.
16. Stoppler H, Stoppler MC, Schlegal R. Transforming proteins of the papillomaviruses. Intervirology 1994; 37: 168-179.
17. DiMaio D. Papillomavirus cloning vectors. In: Salzman NP, Howley PM (eds). The Papovaviridae 2. The Papillomaviruses. Plenum: New York, 1987, pp 293-319.
18. Waldenstrom M, Schenstrom K, Sollerbrant K, Hansson L. Replication of bovine papillomavirus vectors in murine cells. Gene 1992; 120: 175-181.
19. Stephens PE, Hentschel CG. The bovine papillomavirus genome and its uses as a eukaryotic vector. Biochem J 1987; 248: 1-11.
20. Zeitlin PL et al. A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection. Am J Resp Cell Mol Biol 1991; 4: 313-319.
21. Alton E, Geddes D. The prospects for gene therapy in cystic fibrosis. Curr Opin Pulmon Med 1995; 1: 471-477.
22. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 1967; 26: 365-369.
23. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning - A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, New York, 1989.
24. Gopalakrishnan V, Walker S, Khan SA. Stimulation of human papillomavirus type 1a DNA replication by a multimerized AT-rich palindromic sequence. Virology 1995; 214: 301-306.
25. Fuchs PG, Pfister H. Transcription of papillomavirus genomes. Intervirology 1994; 37: 159-167.
26. Mack DH, Laimins LA. A keratinocyte-specific transcription factor, KRF-1, interacts with AP-1 to activate expression of human papillomavirus type 18 in squamous epithelial cells. Proc Natl Acad So USA 1991; 88: 9102-9106.
27. Altman A, Jochmus I, Rosl F. Intra-and extracellular control mechanisms of human papillomavirus infection. Intervirology 1994; 37: 180-188.
28. Lin Y-L et al. Progression from papilloma to carcinoma is accompanied by changes in antibody response to papillomavirus proteins. J Virol 1993; 67: 382-389.
29. Dollard SC et al. Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. Genes Dev 1992; 6: 1131-1142.
30. Frattini MG et al. Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates. J Virol 1997; 71: 7068-7072.
31. Touze A, Coursaget P. In vitro gene transfer using human papillomavirus-like particles. Nucleic Acids Res 1998; 26: 1317-1323.
32. Fraefel JC, Breakefield XO. Hybrid vectors: a new generation of virus-based vectors designed to control the cellular fate of delivered genes. Gene Therapy 1997; 4: 1281-1283.
33. Johnston KM et al. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells. Hum Gene Ther 1997; 8: 359-370.
34. Fisher KJ et al. A novel adenovirus adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome. Hum Gene Ther 1996; 7: 2079-2087.
35. Wang S, Vos J-M. A hybrid herpesvirus infectious vector based on Epstein-Barr virus and herpes simplex virus type 1 for gene transfer into human cells in vitro and in vivo. J Virol 1996; 70: 8422-8430.